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CHAPTER 14
Biosensing and Study of
Biological Cells using
Hyperpolarized 129Xe
PATRICK BERTHAULT* AND CE´LINE BOUTIN
CEA Saclay, IRAMIS, NIMBE, UMR CEA/CNRS 3685, Laboratoire Structure
et Dynamique par Re´sonance Magne´tique, 91191 Gif sur Yvette, France
*Email: patrick.berthault@cea.fr
14.1 Introduction
Among the species in which nuclear spin can be transiently polarized, xenon
has a special place for the study of biological processes due to its physical
properties. It has no toxicity, it can be easily handled due to a freezing point
at 162 K. Importantly, its large electron cloud gives this atom specific
chemical aﬃnities, and a large variability of its NMR parameters: the
chemical shift of the monoatomic species has been shown to span a range
from 0 ppm (gas phase) to 300 ppm (solid phase1), longitudinal relaxation
time values range from ca. 5 seconds (xenon in blood2) to several hours. Its
solubility in many biological fluids (a few mM per atm in water at room
temperature, hundreds of mM in lipids) makes it a powerful spy of biological
events.
In the aim of characterizing biological environments and events, xenon
can be used alone, or functionalized by dedicated molecular systems for
which it has a high aﬃnity. These systems bear ligands that enable active
targeting of biological receptors. This chapter aims at summarizing some of
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the recent research and development we have developed using free hyper-
polarized xenon and xenon in molecular hosts to image or characterize
biological cell receptors.
14.2 Hyperpolarized Xenon and Biological Cells
The first experiments dealing with hyperpolarized xenon and biological cells
were performed in 1995 by Albert et al.2 They showed that xenon in the
presence of red blood cells (RBC) gave rise to two signals on the NMR
spectrum (one assigned to xenon in the plasma and the other one to xenon
in RBC) exhibiting diﬀerent longitudinal relaxation times. Bifone et al.3
attributed the 20–24 ppm chemical shift diﬀerence between the two
signals to the interaction between xenon and hemoglobin present in the
intracellular compartment of RBC, the paramagnetism of this protein being
in large part responsible for the chemical shift variation. The variation of
the chemical shift diﬀerence and relaxation time was later correlated to the
oxygenation level of hemoglobin.4
Recently, prokaryotic, eukaryotic cells, mammalian, vegetal, and yeast
cells were studied in the presence of hyperpolarized xenon (Figure 14.1), and
the presence of two signals on the 129Xe NMR spectrum could be system-
atically observed, even in the absence of a known paramagnetic system: one
signal at lower magnetic field corresponding to xenon in the intracellular
compartment and the second one to xenon in the bulk.5 This means that
xenon crosses the plasma membrane while keeping its polarization and that
the exchange rate between both compartments is lower than the frequency
diﬀerence between both environments. Recently it has thus been pointed
out that each cell type has its own signature on the 129Xe NMR spectrum. As
expected, the area of the signal of xenon in the inner compartment is directly
proportional to the number of cells, and the presence of a mixture of cells
can straightforwardly be detected, as well as the cell uptake of toxics.
But undoubtedly the most important point is that the presence of distinct
signals for the inner compartment and the bulk enables measurement of the
xenon in–out exchange rate with simple 129Xe NMR experiments. This gives
direct access to parameters usually diﬃcult to obtain: the fluidity and
permeability of the cell membrane.
We used this property for diﬀerent applications, among which the most
striking was the recognition of cells resistant to chemotherapy.6
Most of the chemotherapeutic agents are small hydrophobic molecules
that cross the cell membrane in a passive (energy-free) way based on a
concentration gradient. But some cells, have developed a membrane trans-
porter system, notably via p-glycoprotein (Pgp),7 in order to favor expelling of
the cytotoxic drugs to the external medium. Whereas cell permeability to
water is now well measured and understood, few methods are proposed to
evaluate cell permeability to hydrophobic drugs.8 The in vitro techniques
used so far are, for example, based on the detection of the internalization
of small hydrophobic fluorophores such as rhodamine 123,9 and PCR
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methods10 which witness the presence and activity of p-glycoprotein. These
techniques are slow as they require an incubation delay. There is thus a real
need for fast evaluation of cell permeability.
In our proof-of-concept, two Chinese Hamster Ovary cell lines were used:
the wild type (LR73-S) sensitive to chemotherapeutic drugs, and the multi-
drug resistant type derived from it (LR73-R). This system had already been
used several times as a model for studying cell drug resistance via Fourier
transform infrared spectroscopy11 and fluorescence correlation spec-
troscopy.12 While after trypsination, classical optical microscopy did not
allow us to discriminate LR73-S and LR73-R cells from their size or aspect,
their one-scan 129Xe NMR spectra recorded in the same conditions (same
temperature, same amount of xenon and number of cells) revealed two
immediate diﬀerences (Figure 14.1): (i) for the same number of cells, the
ratios R between the signal areas of the inner and outer compartments
diﬀered by a factor 3.3 (see Table 14.1): the number of xenon atoms in-
ternalized per cell was in our experimental conditions more than three times
Figure 14.1 129Xe NMR spectra obtained for suspensions of diﬀerent living cell
types. The samples contained red blood cells, Synechocystis cyano-
bacteria, NRK-52E renal proximal cells, Escherichia coli TOP10 bacteria
and Chinese Hamster Ovary LR73 cell lines (left: sensitive to chemo-
therapy; right: resistant to chemotherapy. See text).
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more elevated in the sensitive cell line than in the resistant cell line; (ii) the
chemical shift diﬀerence significantly varied between the two cell lines: the
inner xenon signal for the resistant cell line was low-field shifted by about
1.5 ppm with respect to the signal from sensitive cells. The observed
chemical shift variation can be explained by the diﬀerence of plasma
membrane structure, due to the over-expression of p-glycoprotein, which
organizes its own micro-environment.13
However as variation of the xenon chemical shift could also be due to the
presence of toxics or of other paramagnetic proteins, we undertook the
measurement of a third parameter: the xenon exchange rate across the cell
membrane. This was performed via a simple 1D NMR experiment consisting
of selective inversion of the xenon signal in the cell and acquisition after a
variable delay (Figure 14.2).
The last two columns of Table 14.1 give the exchange rates of xenon in and
out of the cells. The xenon out rate was three times more elevated for the
resistant cell line than for the sensitive cell line, whereas the in rates were
similar. It is worth mentioning that in principle there is no direct correlation
between xenon out rate and drug resistance, as the noble gas has no role in
the cell metabolism. But xenon seems to be assimilated to a small hydro-
phobic molecule, recognized as such by the cells and thus behaves similarly
as some anticancer drugs or antibiotics with respect to trans-membrane
exchange mechanisms. An elevated xenon eﬄux rate thus seems to be the
signature of the mechanism of active elimination of cytotoxic molecules at
the origin of resistance to drugs. Such a marked diﬀerence in xenon-out rate
could be explained by a pronounced action of p-glycoprotein, and anyway
represents a very eﬃcient way to discriminate resistant and sensitive
cell lines.
In order to assess the validity of our interpretation, the eﬀect of
cyclosporine-A (CsA), a revertant agent was tested. CsA is known to interact
with p-glycoprotein and to block its action. The same 129Xe NMR
experiments were performed in two other cell samples of LR73-S and LR73-R
Table 14.1 Results of the 129Xe NMR experiments in terms of chemical shift
diﬀerence, integral ratio (cell/bulk) R and xenon in- and out-exchange








LR73-S 3.00 0.21 0.561 0.022 29.4 5.7 16.5 3.8
LR73-R 4.46 0.05 0.167 0.066 86.5 16.7 14.4 6.3
LR73-SþCsAc 3.00 0.10 0.168 0.024 32.2 27.6 5.4 2.3
LR73-RþCsAc 2.70 0.04 0.113 0.038 28.9 7.8 3.2 2.8
aThe data of the first two rows were obtained with 108 cells, those of rows 3 and 4 with 4107
cells (explaining the diﬀerences in R value).
bThe measures were performed on 5 diﬀerent replicate samples. The error corresponds to
standard deviation. The signals in the high field regions of the 129Xe spectra were fitted by
Lorenzians. After all these experiments, it was checked by colorimetric trypan blue exclusion
test that the cells were still alive.
cCsA: cyclosporin-A.
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cell lines incubated with cyclosporine-A. The 129Xe NMR parameters for the
LR73-S cells were not significantly aﬀected by the incubation. But remark-
ably the characteristics of the spectrum of the LR73-R sample were now close
to these of the sensitive cell sample: smaller chemical shift diﬀerence,
higher number of internalized xenon atoms per cell and xenon out rate lower
than without cyclosporine-A (compare lines 2 and 4 of Table 14.1). This
experiment was repeated several times with diﬀerent cell concentrations
(from 10 to 150million in 530 mL solution), and gave similar results.
Obviously the higher xenon out rate for cells resistant to chemotherapy
combined with a constant – but cell concentration dependent for a given
quantity of noble gas – xenon in rate led to a lower ratio R between the signal
areas of the inner and outer compartments.
As far as we know, no other NMR method exists for the determination of
the permeability of the cell membrane to hydrophobic molecules. The
proposed method is quick and straightforward, and does not require the use
of a model. It only needs a high field NMR spectrometer or imager equipped
with a standard probe and hyperpolarized xenon. The in vivo extension can
be envisioned in localized spectroscopy. On a dense tumor, spatial selection
Figure 14.2 Measurement of the xenon in–out exchange rates. (a) NMR sequence.
(b) Hyperpolarized 129Xe NMR spectra obtained for various delays D on
a sample of LR73-R cells. (c) Result of the exchange experiment:
normalized area of the intra-cell signal as a function of D for LR73-S
and LR73-R cell lines. The curves represent the best fit to the theoretical
equation AB exp( kD), where k¼ kinþ kout. For extracting kin and
kout, we used R¼ kin/kout.
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of a region where a given cell line predominates should enable its analysis
via the 129Xe NMR spectrum.
14.3 Xenon in Functionalized Host Systems
Using hyperpolarized xenon alone as a sensor for biological cells requires,
however, a homogeneous magnetic field. Except for some cells, such as RBCs
or cyanobacteria, the low frequency diﬀerence between the signals of xenon
in the bulk and in the cell compartment should not enable direct in vivo use.
Furthermore, even if the previous paragraph and very recent developments
show that a significant contrast can be observed on endogenous xenon host
systems such as cells, gas vesicles14 and spores,15 where there is a large
number of low-to-intermediate aﬃnity sites, to date none of these systems is
able to target specific biological receptors. Therefore, several molecular
systems for which xenon develops a particular aﬃnity and that give the
noble gas a specific resonance frequency well resolved from the bulk signal,
have been chemically decorated with biological ligands: microporous
nanoparticles,16 cage-molecules17–20 and capsids.21,22 The important
parameters are the ‘in’ resonance frequency (that must be very diﬀerent from
the frequency of the bulk signal), the in–out xenon exchange (that must be
slower than this frequency diﬀerence but fast enough to enable further gain
in sensitivity), and the xenon binding constant (a high aﬃnity is useful when
the xenon/host concentration ratio is low).
Most of the biological sites/receptors and mechanisms that have been
targeted so far after the proof-of-concept made on the avidin–biotin system23
are enzymes24,25 and cell-surface receptors.26–28 The reason lies in the
necessity to increase the local density of xenon hosts, using the catalytic
cycle in the first case or the possible high number of receptors per cell and
cell-internalization in the second case.
A biosensor proposed by Dmochowki et al. was based on a cryptophane-A
linked to a RGD peptide.29,30 The interaction of the biosensor with integrin
induced a variation of the caged xenon frequency. Fluorescence of a Cy3
label showed internalization of the construct, but no 129Xe spectrum of the
biosensor in the cell was presented.
The spatial resolution obtained in classical MRI is not suﬃcient to enable
distinction between the intra-cellular compartment and the bulk in 129Xe
MRI experiments. Therefore, in order to prove that targeting of cell-surface
receptors was achieved, bimodal (fluorescence–129Xe NMR) biosensors
were conceived. Our group chose the transferrin system,28 responsible for
the transport of iron to cells, for several reasons. (i) Transferrin receptors are
cell surface receptors which are internalized when transferrin is recognized.
(ii) Some cells such as K562 erythroleukaemic cells exhibit a high number of
receptors (more than 105). (iii) Labeling transferrin, an 80 kDa protein, by a
small molecule (the cryptophane) is not expected to modify drastically the
biological activity. (iv) The aﬃnity of holo-transferrin for the receptor is
700 times higher than that of apo-transferrin, and obviously the presence of
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the strongly paramagnetic Fe31 ions could lead to fast xenon relaxation
and could aﬀect the sensitivity of the technique. But in case of a too drastic
relaxation, iron ions could have been replaced by indium ions. (v) In our
approach a cryptophane bearing an activated ester was synthesized. This
enabled a non-specific (statistical) grafting of the cryptophane on some
lysine residues of the protein (Figure 14.3a). Thus, various biosensors are
easily built via this method.
Fluorescence microscopy showed the internalization of the biosensor in
K562 cells (Figure 14.3b). After proper washing designed to separate the cells
from the supernatant, the hyperpolarized 129Xe NMR spectra were recorded.
Figure 14.3 Cell internalization of a 129Xe NMR-based biosensor. (a) Structure of the
transferrin biosensor, where some cryptophane (Cr) and Rhodamine
Green (Rh) moieties are non-specifically grafted on the Lys residues of
the protein. (b) Fluorescence microscopy image of K562 cells incubated
with this biosensor. (c)–(e) High field region of the 129Xe spectra of (c) the
transferrin biosensor in the supernatant, (d) the transferrin biosensor in
the cell suspensions, (e) the BSA biosensor in the cell suspensions.
Adapted from ref. 28.
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The spectrum of the cell part is characterized by the presence of two signals
at high field, separated by 10 ppm (Figure 14.3d). The first one (at 68 ppm)
has the same chemical shift as the biosensor in the supernatant and the
second peak represents the biosensor in the cell membrane. This indicates
the internalization process of the transferrin biosensor even if the hydro-
phobicity of cryptophane induces a non-specific interaction of the probe
with the plasma membrane of the cells. For comparison, a construct based
on bovine serum albumin (BSA) was also designed. This protein was known
to give rise to non-specific interactions with cells. After washing, the 129Xe
NMR spectrum of the cell part displayed the same signals but with a lower
overall intensity and a ratio largely in favor of the membrane location
(Figure 14.3e). This is in agreement with the fact that such a construct is
internalized via pinocytosis.31 This leads to the conclusion that although the
transferrin biosensor is recognized and internalized by the cells, a part of
the interaction occurs with the cell membrane, undoubtedly due to the
hydrophobic character of the cryptophane.
Note that Klippel et al. recently used such a non-specific interaction of
hydrophobic cryptophane moieties with the plasma membrane to perform
MRI using the contrast between xenon in the free cage and xenon in the
cage in interaction with the membranes for the purpose of cell-labeling.32
Palaniappan et al. designed a biosensor where many cryptophanes are grafted
on a bacteriophage expressing antibodies against EGFR (Epithelium Growth
Factor Receptor).26 They revealed, via HyperCEST, the specific interaction
between the biosensor and the cell surface receptors.
14.4 Optimized Detection
The exchange of xenon between diﬀerent environments, each having its own
129Xe NMR spectral signature, is the advantage of the use of hyperpolarized
xenon. It enables replenishment of the hyperpolarization after it has been
destroyed by rf excitation or irradiation. Thus two methods can be used to
detect the small reservoir constituted by xenon in cell (Xe@cell) or in a
biosensor (Xe@host): directly with a series of soft pulses at the small
reservoir frequency,33 each followed by detection, or indirectly via detection
of the variation of the bulk xenon signal after irradiation at the small
reservoir frequency (HyperCEST34). The latter method has the advantage of
being more sensitive, but the transient character of the hyperpolarization
requires a continuous and homogeneous supply of polarized gas. Indeed
except using normalization protocols, the lowest detectable amount of xenon
in its host system or in the cell cannot be lower than the fluctuation level of
supplied xenon magnetization.
As a way-around, we extended to xenon a method recently proposed
to provide in one or two scans the whole Z-spectrum.35 A field gradient
applied during the rf irradiation enables saturation of the small reservoir
in a region of the NMR tube. Detection performed in the presence of a
second field gradient decodes to give the Z-spectrum (Figure 14.4).36,37
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Therefore, reliable results can be obtained even with significantly fluctuating
xenon magnetization between pulses, and averaging can now be performed
on a spectrum-by-spectrum basis (adding several UFZ-spectra to increase
the signal-to-noise ratio). The robustness of UFZ toward magnetic field
inhomogeneity is a further advantage of the approach.
14.5 Concluding Remarks
These few examples reveal how hyperpolarized xenon can be a potent probe
of intra-cellular processes. In our laboratory these research eﬀorts will be
continued by (i) still reducing the number of cells needed for detection with
help of micro-fluidics and micro-detection, (ii) developing the concept of a
‘smart’ probe, where a signal transduction inside the cell induces a
xenon frequency shift. Several issues remain unresolved: what is the bio-
distribution of xenon inside the cells that gives rise to such chemical shift
Figure 14.4 129Xe Ultrafast Z-spectroscopy. (a) Mixture of hexacarboxylated crypto-
phanes at 6 mM each, with CW saturation during 7.5 s at 2.4 mT (red)
and without saturation (blue). (b)–(c) Sample of 25million S. cerevisiae
in 1.6 mL H2O (estimated volume fraction 0.17%). (b) One-scan
129Xe
NMR spectrum; (c) Two-scan UFZ spectrum (8 s, B1
sat¼ 2.4 mT).
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variations? Is it possible to transfer the xenon polarization to some
metabolites in the cells? There is no doubt that future years will see a keen
interest in the use of polarized xenon for the study of biological cells.
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